Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review

2018 ◽  
Vol 94 ◽  
pp. 203-233 ◽  
Author(s):  
Gerhard Scherer
2011 ◽  
Vol 4 (3) ◽  
pp. 257-270 ◽  
Author(s):  
T. Baldwin ◽  
R. Riley ◽  
N. Zitomer ◽  
K. Voss ◽  
R. Coulombe Jr. ◽  
...  

Filamentous fungi that contaminate livestock feeds and human food supply often produce toxigenic secondary metabolites known as mycotoxins. Among the hundreds of known mycotoxins, aflatoxins, deoxynivalenol, fumonisins, ochratoxin A and zearalenone are considered the most commercially important. Intense research on these mycotoxins, especially aflatoxin, has resulted in the development of 'biomarkers' used to link exposure to disease risk. In the case of aflatoxin this effort has led to the discovery of both exposure and mechanism-based biomarkers, which have proven essential for understanding aflatoxin's potential for causing disease in humans, including subtle effects on growth and immune response. Fumonisin biomarkers have also been used extensively in farm and laboratory animals to study the fumonisin-induced disruption of cellular and systemic physiology which leads to disease. This review summarises the status of mycotoxin biomarker development in humans and animals for the commercially important mycotoxins. Since the fungi responsible for the production of these mycotoxins are often endophytes that infect and colonise living plant tissues, accumulation of mycotoxins in the plant tissues may at times be associated with development of plant disease symptoms. The presence of mycotoxins, even in the absence of disease symptoms, may still have subtle biological effects on the physiology of plants. This review examines the question of whether or not the knowledge gained from mechanistic studies and development of biomarkers in animal and human systems is transferable to the study of mycotoxin effects on plant systems. Thus far, fumonisin has proven amenable to development of mechanism-based biomarkers to study maize seedling disease caused by the fumonisin producer, Fusarium verticillioides. Expanding our knowledge of mechanisms of toxicity and the overt and subtle effects on animal, human, and plant systems through the identification and validation of biomarkers will further our ability to monitor and limit the damage and economic impact of mycotoxins.


F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 12 ◽  
Author(s):  
Stéphanie Boué ◽  
Thomas Exner ◽  
Samik Ghosh ◽  
Vincenzo Belcastro ◽  
Joh Dokler ◽  
...  

The US FDA defines modified risk tobacco products (MRTPs) as products that aim to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products.  Establishing a product’s potential as an MRTP requires scientific substantiation including toxicity studies and measures of disease risk relative to those of cigarette smoking.  Best practices encourage verification of the data from such studies through sharing and open standards. Building on the experience gained from the OpenTox project, a proof-of-concept database and website (INTERVALS) has been developed to share results from both in vivo inhalation studies and in vitro studies conducted by Philip Morris International R&D to assess candidate MRTPs. As datasets are often generated by diverse methods and standards, they need to be traceable, curated, and the methods used well described so that knowledge can be gained using data science principles and tools. The data-management framework described here accounts for the latest standards of data sharing and research reproducibility. Curated data and methods descriptions have been prepared in ISA-Tab format and stored in a database accessible via a search portal on the INTERVALS website. The portal allows users to browse the data by study or mechanism (e.g., inflammation, oxidative stress) and obtain information relevant to study design, methods, and the most important results. Given the successful development of the initial infrastructure, the goal is to grow this initiative and establish a public repository for 21st-century preclinical systems toxicology MRTP assessment data and results that supports open data principles.


2017 ◽  
Vol 65 (4) ◽  
pp. 944-950 ◽  
Author(s):  
Xiang Tong ◽  
Min Bai ◽  
Weiya Wang ◽  
Qingbing Han ◽  
Panwen Tian ◽  
...  

Toxics ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. 37
Author(s):  
Robert J. Turesky ◽  
Kun Lu

Biomarkers of environmental toxicants are measures of exposures and effects, some of which can serve to assess disease risk and interindividual susceptibilities [...]


Maturitas ◽  
2010 ◽  
Vol 66 (2) ◽  
pp. 163-171 ◽  
Author(s):  
J.K. Prasain ◽  
S.H. Carlson ◽  
J.M. Wyss

Sign in / Sign up

Export Citation Format

Share Document